SAINT PETERSBURG, Russia--(BUSINESS WIRE)--The trastuzumab biosimilar, to be marketed under the trade name HERtiCAD™, is the first trastuzumab biosimilar to receive authorization from the Russian ...

On March 30, 2020, Russian pharmaceutical company, Biocad, announced that it and its partner, ICM d.o.o., recently obtained European registration certification in Bosnia and Herzegovina for two cancer ...

An appeals court tossed a lawsuit from a Russian drugmaker accusing Roche of anticompetitive conduct. (Roche) Roche has once again escaped a lawsuit claiming it went to illegal lengths to block ...

Russian biotech Biocad said it reached a deal with Sothema Labs of Morocco to produce biosimilars rituximab and bevacizumab, used to treat cancer. The St. Petersburg-based company said the drugs, ...

The biotechnology company BIOCAD has signed an agreement with the State Scientific Center for Virology and Biotechnology &laquoVektor» (Novosibirsk) on joint work on a vaccine based on rVSV against ...

MOSCOW (Reuters) - Biotech group Biocad is discussing producing in China a potential COVID-19 vaccine being developed by Russia's Vector state virology institute, the director of the St ...

The biotechnology company BIOCAD has signed an agreement with the State Scientific Center for Virology and Biotechnology «Vektor» (Novosibirsk) on joint work on a vaccine based on rVSV against the ...

SAINT PETERSBURG, Russia--(BUSINESS WIRE)--Russian biotechnology company BIOCAD and Moroccan pharmaceutical company Sothema Labs announced the launch of medicines derived using the technology provided ...

Clinical trials of the vaccine are currently underway. The &laquoSputnik V» is the two-component vaccine. Revaccination is carried out at intervals of 3-4 weeks. Moreover, with the repeated ...

Netakimab is a humanized anti-interleukin 17A antibody approved for the treatment of moderate-to-severe plaque psoriasis. Phase three clinical trial PATERA evaluated the effects of netakimab on signs ...

Biocad, a Russian biotechnology company that’s trying to copy some of the world’s top-selling cancer medicines, is seeking a buyer, said two people with direct knowledge of the matter. Biocad may be ...

Add Yahoo as a preferred source to see more of our stories on Google. A logo of BIOCAD company is seen on a door at the company's production facility in Saint Petersburg MOSCOW (Reuters) - Biotech ...